| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |